Increased expression of matrix metalloproteinase 9 and tubulin-α in pulmonary sclerosing hemangioma

Oncology Reports

Volumn 18, Issue 5, 2007, Pages 1139-1144

  Cho, Su Jin ^a,b   Jin, Lian Jin ^a,b   Kim, Bu Yeo ^d   Cho, Su In ^d   Jung, Woon Yong ^a,b   Han, Joung Ho ^b,c   Ha, Seong Yeon ^b,e   Kim, Han Kyeom ^a,b   Kim, Aeree ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Dongshin University   (South Korea)

^e Gachon University   (South Korea)

Author keywords

DNA microarray; Matrix metalloproteinase 9; Pulmonary sclerosing hemangioma; Tissue microarray; Tubulin

Indexed keywords

GELATINASE B; MESSENGER RNA; TUBULIN; TUMOR MARKER;

AGED; ARTICLE; DNA MICROARRAY; ENZYME IMMUNOASSAY; ENZYMOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PULMONARY SCLEROSING HEMANGIOMA; TISSUE MICROARRAY;

AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY SCLEROSING HEMANGIOMA; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; TUBULIN; TUMOR MARKERS, BIOLOGICAL;

EID: 38449098637     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Niho S, Suzuki K, Yokose T, Kodama T, Nishiwaki Y and Esumi H: Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol 152: 1065-1069, 1998. (Pubitemid 28173368)
2. Fukayama M and Koike M: So-called sclerosing hemangioma of the lung. An immunohistochemical, histochemical and ultrastructural study. Acta Pathol Jpn 38: 627-642, 1988.
3. Wang E, Lin D, Wang Y, Wu G and Yuan X: Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol 35: 503-508, 2004. (Pubitemid 38507089)
4. Kim KH, Sul HJ and Kand DY: Sclerosing hemangioma with lymph node metastasis. Yonsei Med J 44: 150-154, 2003.
5. Komatsu T, Fukuse T, Wada H and Sakurai T: Pulmonary sclerosing hemangioma with pulmonary metastasis. Thorac Cardiovasc Surg 54: 348-349, 2006. (Pubitemid 44366246)
6. Yamazaki K: Type-II pneumocyte differentiation in pulmonary sclerosing hemangioma:ultrastructural differentiation and immunohistochemical distribution of lineage-specific transcription factors (TTF-1, HNF-3 alpha, and HNF-3 beta) and surfactan t proteins. Virchows Arch 445: 45-53, 2004.
7. Yoo SH, Jung KC, Kim JH, et al: Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues. Arch Pathol Lab Med 129: 915-919, 2005. (Pubitemid 40934312)
8. Wu CT, Chang YL and Lee YC: Expression of the estrogen receptor beta in 37 surgically treated pulmonary sclerosing hemangiomas in comparison with non-small cell lung carcinomas. Hum Pathol 36: 1108-1112, 2005.
9. Yang YH, Dudoit S, Luu P, et al: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15, 2002.
10. Jin LJ, Shin BK, Jung WY, et al: Proteomic analysis of pulmonary sclerosing hemangioma. Proteomics 6: 4877-4883, 2006. (Pubitemid 44369066)
11. Dasu MR, Barrow RE, Hawkins HK and McCauley RL: Gene expression profiles of giant hairy naevi. J Clin Pathol 57: 849-855, 2004. (Pubitemid 39061435)
12. Olivier RI, van Beurden M and Van' T Veer LJ: The role of gene expression profiling in the clinical management of ovarian cancer. Eur J Cancer 42: 2930-2938, 2006.
13. Hou YF, Yuan ST, Li HC, et al: ERβ exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 23: 5799-5806, 2004.
14. Grimberg A and Cohen P: Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 183: 1-9, 2000. (Pubitemid 30130219)
15. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM and Egger M: Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 136-153, 2004.
16. Leahy M, Lyons A, Krause D and O'Connor R: Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like factor I receptor mutated at tyrosines 1250 and 1251. J Biol Chem 279: 18306-18313, 2004. (Pubitemid 38623245)
17. Stiles AD and D'Ercole AJ: The insulin-like growth factors and the lung. Am J Respir Cell Mol Biol 3: 93-100, 1990. Science and Engineering Foundation